AVT 01 / AnGes MG - LARVOL DELTA

In vivo characterization of [F]AVT-011 as a radiotracer for PET imaging of multidrug resistance. (PubMed, Eur J Nucl Med Mol Imaging) - "[F]AVT-011 is a dual ABCB1/ABCG2 substrate radiotracer that can quantify transporter function at the blood-brain barrier and in ABCB1-expressing tumors, making it potentially suitable for clinical imaging of ABCB1-mediated MDR in tumors."

Journal • Preclinical • ABCB1 • ABCG2

Safety, Tolerability and Potential Efficacy of AVT001 in Patients With Type 1 Diabetes (clinicaltrials.gov) - P1/2; N=24; Recruiting; Sponsor: Avotres Inc.; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open

Safety, Tolerability and Potential Efficacy of AVT001 in Patients With Type 1 Diabetes (clinicaltrials.gov) - P1/2; N=24; Not yet recruiting; Sponsor: Avotres Inc.

Clinical • New P1/2 trial